Literature DB >> 34818117

Quantitative retrospective natural history modeling of WDR45-related developmental and epileptic encephalopathy - a systematic cross-sectional analysis of 160 published cases.

Afshin Saffari1,2, Julian Schröter1,2, Sven F Garbade2, Julian E Alecu3, Darius Ebrahimi-Fakhari3, Georg F Hoffmann2, Stefan Kölker2, Markus Ries2, Steffen Syrbe1.   

Abstract

WDR45-related neurodevelopmental disorder (NDD) is a clinically-heterogenous congenital disorder of macroautophagy/autophagy. The natural history of this ultra-orphan disease remains incompletely understood, leading to delays in diagnosis and lack of quantifiable outcome measures. In this cross-sectional study, we model quantitative natural history data for WDR45-related NDD using a standardized analysis of 160 published cases, representing the largest cohort to date. The primary outcome of this study was survival. Age at disease onset, diagnostic delay and geographic distribution were quantified as secondary endpoints. Our tertiary aim was to explore and quantify the spectrum of WDR45-related phenotypes. Survival estimations showed low mortality until 39 years of age. Median age at onset was 10 months, with a median diagnostic delay of 6.2 years. Geographic distribution appeared worldwide with clusters in North America, East Asia, Western Europe and the Middle East. The clinical spectrum was highly variable with a bi-phasic evolution characterized by early-onset developmental and epileptic encephalopathy during childhood followed by a progressive dystonia-parkinsonism syndrome along with cognitive decline during early adulthood. Female individuals showed milder disease severity. The majority of pathogenic WDR45 variants were predicted to result in a loss of WDR45 expression, without clear genotype-phenotype associations. Our results provide clinical and epidemiological data that may facilitate an earlier diagnosis, enable anticipatory guidance and counseling of affected families and provide the foundation for endpoints for future interventional trials.Abbreviations: BPAN: beta-propeller protein-associated neurodegeneration; CNS: central nervous system; DEE: developmental and epileptic encephalopathy; MRI: magnetic resonance imaging; NBIA: neurodegeneration with brain iron accumulation; NDD: neurodevelopmental disorder; NGS: next-generation sequencing; WDR45/WIPI4: WD repeat domain 45.

Entities:  

Keywords:  BPAN; Beta-propeller protein-associated neurodegeneration; DEE; NBIA; NBIA5; NDD; WDR45; WIPI4; congenital disorder of autophagy

Mesh:

Substances:

Year:  2021        PMID: 34818117      PMCID: PMC9298448          DOI: 10.1080/15548627.2021.1990671

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   13.391


  34 in total

Review 1.  Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms.

Authors:  Jesse S Kerr; Bryan A Adriaanse; Nigel H Greig; Mark P Mattson; M Zameel Cader; Vilhelm A Bohr; Evandro F Fang
Journal:  Trends Neurosci       Date:  2017-02-09       Impact factor: 13.837

2.  De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood.

Authors:  Hirotomo Saitsu; Taki Nishimura; Kazuhiro Muramatsu; Hirofumi Kodera; Satoko Kumada; Kenji Sugai; Emi Kasai-Yoshida; Noriko Sawaura; Hiroya Nishida; Ai Hoshino; Fukiko Ryujin; Seiichiro Yoshioka; Kiyomi Nishiyama; Yukiko Kondo; Yoshinori Tsurusaki; Mitsuko Nakashima; Noriko Miyake; Hirokazu Arakawa; Mitsuhiro Kato; Noboru Mizushima; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2013-02-24       Impact factor: 38.330

3.  Age Limit of Pediatrics.

Authors:  Amy Peykoff Hardin; Jesse M Hackell
Journal:  Pediatrics       Date:  2017-08-21       Impact factor: 7.124

4.  Lessons from a pair of siblings with BPAN.

Authors:  Yuri A Zarate; Julie R Jones; Melanie A Jones; Francisca Millan; Jane Juusola; Annette Vertino-Bell; G Bradley Schaefer; Michael C Kruer
Journal:  Eur J Hum Genet       Date:  2015-11-18       Impact factor: 4.246

5.  β-propeller proteins WDR45 and WDR45B regulate autophagosome maturation into autolysosomes in neural cells.

Authors:  Cuicui Ji; Hongyu Zhao; Di Chen; Hong Zhang; Yan G Zhao
Journal:  Curr Biol       Date:  2021-02-25       Impact factor: 10.834

6.  Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy.

Authors:  Mattia Fonderico; Michele Laudisi; Nico Golfrè Andreasi; Stefania Bigoni; Costanza Lamperti; Celeste Panteghini; Barbara Garavaglia; Miryam Carecchio; Elia Antonio Emanuele; Gian L Forni; Enrico Granieri
Journal:  Front Neurol       Date:  2017-08-21       Impact factor: 4.003

7.  Single-center experience with Beta-propeller protein-associated neurodegeneration (BPAN); expanding the phenotypic spectrum.

Authors:  Marisa Chard; Juan Pablo Appendino; Luis E Bello-Espinosa; Colleen Curtis; Jong M Rho; Xing-Chang Wei; Walla Al-Hertani
Journal:  Mol Genet Metab Rep       Date:  2019-06-19

8.  Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.

Authors:  Tobias B Haack; Penelope Hogarth; Michael C Kruer; Allison Gregory; Thomas Wieland; Thomas Schwarzmayr; Elisabeth Graf; Lynn Sanford; Esther Meyer; Eleanna Kara; Stephan M Cuno; Sami I Harik; Vasuki H Dandu; Nardo Nardocci; Giovanna Zorzi; Todd Dunaway; Mark Tarnopolsky; Steven Skinner; Steven Frucht; Era Hanspal; Connie Schrander-Stumpel; Delphine Héron; Cyril Mignot; Barbara Garavaglia; Kailash Bhatia; John Hardy; Tim M Strom; Nathalie Boddaert; Henry H Houlden; Manju A Kurian; Thomas Meitinger; Holger Prokisch; Susan J Hayflick
Journal:  Am J Hum Genet       Date:  2012-11-21       Impact factor: 11.025

9.  A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy.

Authors:  Shen-Yang Lim; Ai Huey Tan; Azlina Ahmad-Annuar; Susanne A Schneider; Ping Chong Bee; Jia Lun Lim; Norlisah Ramli; Mohamad Imran Idris
Journal:  J Mov Disord       Date:  2018-05-30

10.  Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.

Authors:  Afshin Saffari; Ines Brösse; Adelheid Wiemer-Kruel; Bernd Wilken; Paula Kreuzaler; Andreas Hahn; Matthias K Bernhard; Cornelis M van Tilburg; Georg F Hoffmann; Matthias Gorenflo; Sven Hethey; Olaf Kaiser; Stefan Kölker; Robert Wagner; Olaf Witt; Andreas Merkenschlager; Andreas Möckel; Timo Roser; Jan-Ulrich Schlump; Antje Serfling; Juliane Spiegler; Till Milde; Andreas Ziegler; Steffen Syrbe
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123

View more
  2 in total

Review 1.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

2.  Damaging novel mutations in PIGN cause developmental epileptic-dyskinetic encephalopathy: a case report.

Authors:  Maoqiang Tian; Jing Chen; Juan Li; Hong Pan; Wenting Lei; Xiaomei Shu
Journal:  BMC Pediatr       Date:  2022-04-25       Impact factor: 2.567

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.